Abstract
To determine why proteasome inhibitors prevent thymocyte death, we examined whether proteasomes degrade anti-apoptotic molecules in cells induced to undergo apoptosis. The c-IAP1 and XIAP inhibitors of apoptosis were selectively lost in glucocorticoid- or etoposide-treated thymocytes in a proteasome-dependent manner before death. IAPs catalyzed their own ubiquitination in vitro, an activity requiring the RING domain. Overexpressed wild-type c-IAP1, but not a RING domain mutant, was spontaneously ubiquitinated and degraded, and stably expressed XIAP lacking the RING domain was relatively resistant to apoptosis-induced degradation and, correspondingly, more effective at preventing apoptosis than wild-type XIAP. Autoubiquitination and degradation of IAPs may be a key event in the apoptotic program.
MeSH terms
-
Animals
-
Apoptosis*
-
Cells, Cultured
-
Cysteine Endopeptidases / metabolism*
-
Dexamethasone / pharmacology
-
Etoposide / pharmacology
-
Hybridomas
-
Inhibitor of Apoptosis Proteins
-
Ligases / metabolism*
-
Mice
-
Mice, Inbred C57BL
-
Multienzyme Complexes / metabolism*
-
Proteasome Endopeptidase Complex
-
Protein Structure, Tertiary
-
Proteins / chemistry
-
Proteins / genetics
-
Proteins / metabolism*
-
Recombinant Fusion Proteins / metabolism
-
T-Lymphocytes / cytology
-
T-Lymphocytes / drug effects
-
T-Lymphocytes / metabolism*
-
Thymus Gland / cytology
-
Transfection
-
Ubiquitin-Protein Ligases
-
Ubiquitins / metabolism
-
X-Linked Inhibitor of Apoptosis Protein
Substances
-
Inhibitor of Apoptosis Proteins
-
Multienzyme Complexes
-
Proteins
-
Recombinant Fusion Proteins
-
Ubiquitins
-
X-Linked Inhibitor of Apoptosis Protein
-
Etoposide
-
Dexamethasone
-
Birc2 protein, mouse
-
Ubiquitin-Protein Ligases
-
Cysteine Endopeptidases
-
Proteasome Endopeptidase Complex
-
Ligases